B of A Securities Maintains Buy on CVS Health, Raises Price Target to $110
سي في اس كيرمارك
CVS Health Corporation CVS | 0.00 |
B of A Securities analyst Allen Lutz maintains CVS Health (NYSE:
CVS) with a Buy and raises the price target from $100 to $110.
